Have a feature idea you'd love to see implemented?
Let us know!
INGN Inogen Inc
Price (delayed)
$9.21
Market cap
$219.37M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.25
Enterprise value
$130.23M
Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental
Highlights
Inogen's EPS has soared by 61% YoY and by 43% from the previous quarter
Inogen's net income has soared by 60% YoY and by 43% from the previous quarter
The quick ratio has contracted by 29% YoY
The equity has declined by 20% year-on-year
Key stats
What are the main financial stats of INGN
Market
Valuations
Earnings
Shares outstanding
23.82M
Market cap
$219.37M
Enterprise value
$130.23M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.18
Price to sales (P/S)
0.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.39
Revenue
$331.52M
EBIT
-$53.48M
EBITDA
-$32.41M
Free cash flow
-$14.47M
Per share
Balance sheet
Liquidity
EPS
-$2.25
Free cash flow per share
-$0.61
Book value per share
$7.82
Revenue per share
$13.96
TBVPS
$11.04
Total assets
$306.17M
Total liabilities
$120.77M
Debt
$20.15M
Equity
$185.4M
Working capital
$120.16M
Debt to equity
0.11
Current ratio
2.66
Quick ratio
2.19
Net debt/EBITDA
2.75
Margins
Efficiency
Dividend
EBITDA margin
-9.8%
Gross margin
44.2%
Net margin
-15.9%
Operating margin
-18.1%
Return on assets
-16.8%
Return on equity
-27.4%
Return on invested capital
-49.4%
Return on capital employed
-22.9%
Return on sales
-16.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INGN stock price
How has the Inogen stock price performed over time
Intraday
-2.64%
1 week
-7.44%
1 month
1.21%
1 year
58.25%
YTD
67.76%
QTD
-5.05%
Financial performance
How have Inogen's revenue and profit performed over time
Revenue
$331.52M
Gross profit
$146.61M
Operating income
-$60.11M
Net income
-$52.69M
Gross margin
44.2%
Net margin
-15.9%
The net margin has soared by 61% year-on-year and by 44% since the previous quarter
Inogen's net income has soared by 60% YoY and by 43% from the previous quarter
INGN's operating income has surged by 57% year-on-year and by 39% since the previous quarter
The operating margin has soared by 57% YoY and by 40% from the previous quarter
Growth
What is Inogen's growth rate over time
Valuation
What is Inogen stock price valuation
P/E
N/A
P/B
1.18
P/S
0.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.39
Inogen's EPS has soared by 61% YoY and by 43% from the previous quarter
INGN's P/B is 41% below its 5-year quarterly average of 2.0 but 18% above its last 4 quarters average of 1.0
The equity has declined by 20% year-on-year
The stock's price to sales (P/S) is 65% less than its 5-year quarterly average of 1.9 but 10% more than its last 4 quarters average of 0.6
Efficiency
How efficient is Inogen business performance
Inogen's ROS has soared by 60% YoY and by 43% from the previous quarter
Inogen's ROA has soared by 52% YoY and by 41% from the previous quarter
INGN's ROIC is up by 47% YoY and by 37% from the previous quarter
Inogen's return on equity has increased by 44% YoY and by 40% QoQ
Dividends
What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INGN.
Financial health
How did Inogen financials performed over time
INGN's total assets is 154% greater than its total liabilities
The quick ratio has contracted by 29% YoY
The company's current ratio fell by 29% YoY
The debt is 89% smaller than the equity
The equity has declined by 20% year-on-year
The debt has declined by 12% year-on-year and by 6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.